Abstract
In conjunction with our understanding of the disease, the role of pathologists has evolved from a pure morphologic assessment to a more active participation in triaging specimens for a host of ancillary studies and incorporating these results into the pathology report in order to refine diagnoses and/or guide therapeutic decisions. As molecular characterization of different types of cancer becomes standard of care, pathologists will continue to play a pivotal role in early diagnosis, monitoring of tumor response, and disease progression of cancer patients. The powerful combination of advanced molecular diagnostics and the minimally invasive nature of cytology specimens that define molecular cytopathology, amplifies our ability to do more with less and propels this new field to the forefront of personalized medicine. Given that many patients present with advanced-stage cancers in whom the diagnosis is made only based on cytology, optimizing and validating cytology specimens for molecular testing is critical.
We review in this chapter, the range of cytology specimens and the different ways in which they can be utilized for various molecular tests.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Further Reading
Balassanian R, Ng DL, Zante A. Stop using expired plasma for cell blocks. Cancer Cytopathol. 2019;127:737–8.
Balla A, Hampel KJ, Sharma MK, Cottrell CE, Sidiropoulos N. Comprehensive validation of cytology specimens for next-generation sequencing and clinical practice experience. J Mol Diagn. 2018;20:812–21.
Dejmek A, Zendehrokh N, Tomaszewska M, Edsjö A. Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality. Cancer Cytopathol. 2013;121:344–53.
Dudley JC, Schroers-Martin J, Lazzareschi DV, et al. Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discov. 2019;9:500–9.
Gillooly JF, Hein A, Damiani R. Nuclear DNA content varies with cell size across human cell types. Cold Spring Harb Perspect Biol. 2015;7:a019091.
Grace A, Kay E, Leader M. Liquid-based preparation in cervical cytology screening. Curr Diagn Pathol. 2001;7(2):91–5.
Guseva NV, Jaber O, Stence AA, Sompallae K, Bashir A, Sompallae R, Bossler AD, Jensen CS, Ma D. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay. Cancer Cytopathol. 2018;126:158–69.
Harada S, Agosto-Arroyo E, Levesque JA, Alston E, Janowski KM, Coshatt GM, Eltoum IA. Poor cell block adequacy rate for molecular testing improved with the addition of diff-quik-stained smears: need for better cell block processing. Cancer Cytopathol. 2015;123:480–7.
Heymann JJ, Yoxtheimer LM, Park HJ, et al. Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: cellularity and storage time. Cancer Cytopathol. 2020;128:656–72.
Hoffman EA, Frey BL, Smith LM, Auble DT. Formaldehyde crosslinking: a tool for the study of chromatin complexes. J Biol Chem. 2015;290:26404–11.
Hwang DH, Garcia EP, Ducar MD, Cibas ES, Sholl LM. Next-generation sequencing of cytologic preparations: an analysis of quality metrics. Cancer Cytopathol. 2017;125:786–94.
Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, Temple-Smolkin RL, Voelkerding KV, Nikiforova MN. Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of American pathologists. J Mol Diagn. 2017;19:341–65.
Kanagal-Shamanna R, Portier BP, Singh RR, et al. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics. Mod Pathol. 2014;27:314–27.
Larson MH, Pan W, Kim HJ, et al. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun. 2021;12:2357.
Liu H, Huang X, Zhang Y, Ye H, El Hamidi A, Kocjan G, Dogan A, Isaacson PG, Du M-Q. Archival fixed histologic and cytologic specimens including stained and unstained materials are amenable to RT-PCR. Diagn Mol Pathol. 2002;11:222–7.
Masumoto N, Fujii T, Ishikawa M, Mukai M, Saito M, Iwata T, Fukuchi T, Kubushiro K, Tsukazaki K, Nozawa S. Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women. Br J Cancer. 2003;88:1883–8.
Monaco SE, Dacic S. Fluorescence in situ hybridization in cytopathology. In: Modern techniques in cytopathology, vol. 25. Basel: Karger; 2019. p. 19–33.
Monaco SE, Teot LA, Felgar RE, Surti U, Cai G. Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. Cancer Cytopathol. 2009;117:338–48.
Pentsova EI, Shah RH, Tang J, et al. Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid. J Clin Oncol. 2016;34:2404–15.
Ramani NS, Chen H, Broaddus RR, et al. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers. Cancer Cytopathol. 2021;129:374–82.
Roy-Chowdhuri S, Chen H, Singh RR, et al. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. Mod Pathol. 2017;30:499–508.
Roy-Chowdhuri S, Mehrotra M, Bolivar AM, et al. Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling. Mod Pathol. 2018;31:1036–45.
Roy-Chowdhuri S, Roy S, Pantanowitz L. Next-generation sequencing in cytopathology. In: Modern techniques in cytopathology, vol. 25. Basel: Karger; 2020. p. 34–42.
Saqi A, Balassanian R. Cell blocks: evolution, modernization, and assimilation into emerging technologies. In: Modern techniques in cytopathology, vol. 25. Basel: Karger; 2020. p. 6–18.
Soltani M, Nemati M, Maralani M, Estiar MA, Andalib S, Fardiazar Z, Sakhinia E. Cell-free fetal DNA in amniotic fluid supernatant for prenatal diagnosis. Cell Mol Biol. 2016;62:14–7.
Sung S, Sireci A, Remotti H, Hodel V, Mansukhani M, Fernandes H, Saqi A. Plasma-thrombin: potential source of DNA contamination in cell blocks. J Am Soc Cytopathol. 2018;7:S5.
Yang S-R, Mooney KL, Libiran P, et al. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology. Cancer Cytopathol. 2020;128:43–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ruiz-Cordero, R., Roy-Chowdhuri, S. (2023). Molecular Cytopathology. In: Cheng, L., Netto, G.J., Eble, J.N. (eds) Molecular Surgical Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-35118-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-35118-1_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35117-4
Online ISBN: 978-3-031-35118-1
eBook Packages: MedicineMedicine (R0)